A comparative study of 99Tcm-d,l-HMPAO and 99Tcm-d,l-CBPAO as leukocyte-labelling agents

Nuclear Medicine Communications

Volumn 17, Issue 1, 1996, Pages 76-79

  Tsai, C S ^a   Kao, C H ^b   Yeh, S J ^a   Wang, S J ^b  

^a NATIONAL TSING HUA UNIVERSITY   (Taiwan)

^b TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; OXIME; TECHNETIUM COMPLEX; TECHNETIUM TC 99M CYCLOBUTYLPROPYLENEAMINE OXIME;

ARTICLE; BLOOD; CELL SURVIVAL; COMPARATIVE STUDY; CYTOLOGY; HUMAN; IN VITRO STUDY; ISOTOPE LABELING; KINETICS; LEUKOCYTE; METHODOLOGY;

CELL SURVIVAL; HUMANS; ISOTOPE LABELING; KINETICS; LEUKOCYTES; ORGANOTECHNETIUM COMPOUNDS; OXIMES; TECHNETIUM TC 99M EXAMETAZIME;

EID: 0029666238     PISSN: 01433636     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006231-199601000-00013     Document Type: Article

References (16)

1. Neirinckx R, Canning L, Piper I et al. Technetium-99m d,l-HM-PAO: A new radiopharmaceutical for SPECT imaging of regional cerebral blood perfusion. J Nucl Med 1987; 28: 191-202.
2. Bacciottini L, Lunghi F, Pupi A et al. Evaluation of technetium-99m cyclobutylpropylene amine oxime as a potential brain perfusion imaging agent for SPET. Eur J Nucl Med 1990; 17: 242-247.
3. Ceretec package insert, Amersham, 1990.
4. Kao CH, Wang YL, Wang SJ. Elution analysis and normal biodistribution of technetium-99m-HMPAO-labeled white blood cells. J Nucl Med Technol 1992; 20: 224-227.
5. Becker W, Schomann E, Fischbach W, Borner W, Gruner KR. Comparison of Tc-99m-HMPAO and In-111-oxime labelled granulocytes in man: First clinical results. Nucl Med Commun 1988; 9: 435-447.
6. McAfee JG, Thakur ML. Survey of radioactive agents for in vitro labelling of phagocytic leucocytes. 1. Soluble agent. J Nucl Med 1976; 17: 480-487.
7. McAfee JG, Thakur ML. Survey of radioactive agents for in vitro labelling of phagocytic leucocytes. 2. Particles. J Nucl Med 1976; 17: 488-492.
8. Peters AM, Roddie ME, Danpure HJ et al. Tc-99m-HMPAO labelled leucocytes: Comparison with In-111-tropolone labelled granulocytes. Nucl Med Commun 1988; 9: 449-463.
9. Mountford PJ, Kettle AG, O'Doherty MJ, Coakley AJ. Comparison of technetium-99m-HM-PAO leukocytes with indium-111-oxime leukocytes for localizing intraabdominal sepsis. J Nucl Med 1990; 31: 311-315.
10. Tubergen K, Corlija M, Volkert WA, Holmes RA. Sensitivity of technetium-99m-d,l-HMPAO to radiolysis in aqueous solutions. J Nucl Med 1991; 32: 111-115.
11. Hung JC, Volkert WA, Holmes RA. Stabilization of Tc-99m-d,l-HMPAO using gentisic acid. Int J Nucl Med Biol 1989; 16: 675-680.
12. Lantto EH, Lantto TJ, Vorne M. Fast diagnosis of abdominal infections and inflammations with technetium-99m-HMPAO labelled leukocytes. J Nucl Med 1991; 32: 2029-2034.
13. Kao CH, Huang WT, Wang YL, Lin KS, Lo JM, Wang SJ. A comparative study of Tc-99m HMPAO and Tc-99m ECD as a leukocyte labelling agent. Nucl Med Commun 1994; 15: 294-297.
14. Colombo F, Libson K, Jiang Z et al. Comparative chemical and biological properties of rCBF agents Tc-99m d,l-CBPAO and Tc-99m d,l-HMPAO. In: Nicolini M, Bandoli G, Mazzi U, eds. Technetium and rhenium in chemistry and nuclear medicine, 3rd edn. Cortina International, 1990: 469-473.
15. Messa C, Zito F, Rossetti C et al. Evaluation of a new tracer for cerebral perfusion studies: Tc-99m d,l-CBPAO. Preliminary results in humans. J Nucl Med 1989; 30: 426 (abstract).
16. Colas-Linhart N. Technique of cell handling and viability testing. In: Fueger GF, ed. Blood cells in nuclear medicine. Part II, Boston: Martinus Nijhoff, 1984: 117-137.